Skip to main content
SpringerLink
Log in

Ziprasidone effectively improves QOL among patients with schizophrenia who are switched from typical and/or atypical antipsychotics,

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Rossi A, Vita A, Tiradritti P, Romeo F.Assessment of clinical and metabolic status, and subjective well-being, in schizophrenic patients switched from typical and atypical antipsychotics to ziprasidone. International Clinical Psychopharmacology 23: 216-222, No. 4, Jul 2008

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziprasidone effectively improves QOL among patients with schizophrenia who are switched from typical and/or atypical antipsychotics,. Pharmacoecon. Outcomes News 559, 13 (2008). https://doi.org/10.2165/00151234-200805590-00038

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200805590-00038

Keywords

Search

Navigation